tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market

Ascentage Pharma Group International (6855) Similar Stocks

Compare
5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ascentage Pharma Group International
HK$53.60
HK$19.85B
-13.67
17.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$13.11
HK$19.59B
-92.85
116.69%
5 Buy
1 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$22.56
HK$35.58B
-21.99
89.26%
0 Buy
1 Hold
1 Sell
Moderate Sell
Everest Medicines Ltd.
HK$51.50
HK$15.78B
-20.35
-3.11%
Simcere Pharmaceutical Group Limited
HK$12.77
HK$33.15B
33.08
90.88%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$60.10
HK$32.66B
36.70
151.46%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6855
Ascentage Pharma Group International
53.60
8.15
17.93%
HK:9969
InnoCare Pharma Ltd.
13.11
7.06
116.69%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
22.56
10.80
91.84%
HK:1952
Everest Medicines Ltd.
44.62
-2.93
-6.16%
HK:2096
Simcere Pharmaceutical Group Limited
12.77
6.08
90.88%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
60.10
36.20
151.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts